The Effect of Distraction Techniques Used in Intramuscular (IM) Injections on Pain in Adolescents Presenting to the Emergency Department With Dysmenorrhea: A Randomized Controlled Study

Launched by DUYGU MEZDE · Feb 21, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how certain techniques can help reduce menstrual pain, also known as dysmenorrhea, in adolescents aged 12 to 18 who come to the emergency department. The techniques being tested include the Helfer Skin Tap Technique (HSTT) and a device called ShotBlocker, which are designed to distract patients during intramuscular (IM) injections to lessen pain without the use of medication. The researchers want to see if these methods can make it easier for young people to manage their menstrual pain and improve their overall well-being.

To participate in the study, teens must be between 12 and 18 years old and have experienced menstrual pain during at least one cycle. They will need to provide written consent, or have a guardian do so, since they will be monitored for several months to track how these techniques affect their pain levels and daily activities. The study is focused on finding better ways to help adolescents cope with menstrual pain, and while the techniques may work differently for everyone, the goal is to enhance pain management options for young patients. Participation carries minimal risks, and the study does not include individuals with certain medical conditions or those who are pregnant.

Gender

FEMALE

Eligibility criteria

• nclusion Criteria:
• • Adolescents aged 12-18 years.
• • Experience of dysmenorrhea (menstrual pain) during at least one menstrual cycle.
• • Adolescents presenting to the emergency department with dysmenorrhea.
• • Written informed consent from participants or their legal guardians.
• Exclusion Criteria:
• • Individuals with severe cardiovascular, neurological, or other serious medical conditions.
• • Pregnant individuals.
• • Individuals undergoing regular hormonal therapy or using birth control methods.
• • Individuals with significant psychological or physiological conditions related to pain sensitivity (e.g., hyperalgesia).
• • Individuals receiving other pharmacological treatments or pain management medications during the study.